UAE Ministry of Health senior officials conduct inspection visit to Globalpharma
Inspection tour part of the MoHAP's strategy aimed at implementing national standards
Press Release - 07-Jan-2020
Globalpharma Co. (L.L.C)
Also known as: Globalpharma Last updated on: 16 September 2019
fast facts
Business SummaryManufacture of generic pharmaceuticals including tablets, capsules, dry syrup and liquid drugs.Country of IncorporationUAEOwnership TypeForeignEstablished In1998Primary SectorHealth CareNumber of Employees170Latest News
HEALTH
Dubai Investments reports net profit of $55mln in Q1 2019
Total assets increased to $5.48bln
WAM (Emirates News Agency) - 05-May-2019Dubai Investments reports net profit in Q1 2019
Increase in gain on fair valuation of investments which is quite encouraging as it indicates improving market conditions
Press Release - 05-May-2019Industry experts address 150 healthcare professionals at Quality in Primary Care Globalpharma seminar
Around 150 healthcare professionals from the UAE, Saudi Arabia and Iraq attended the interactive seminar
Press Release - 16-Mar-2019Poland to promote Biotech and pharma sector in UAE
The Polish Investment and Trade Agency along with leading Polish companies will highlight the country's Bio-Pharma offerings at the upcoming Middle East Pharma Cold Chain Congress in Dubai
Press Release - 14-Mar-2019Contact details
Primary address
Globalpharma Co. (L.L.C) BuildingEmirates Road
Dubai Investment Park
72168
UAE
Dubai
Region
DubaiCONTACT
- Tel: +971 4-885-1222
- Tel: +971 4-809-0900
- Fax: +971 4-885-1223
- Email: info@globalpharma.ae
- www.globalpharma.com
Find Out More Information
Access the most comprehensive database of companies and officers in the Middle East and North Africa, covering all major sectors and industries, from Refinitiv.
Company information provided by © 2020 Thomson Reuters
Thomson Reuters research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).